JULIA BUESSER: Open Payments
NPI 1013390491 · GURNEE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,254 in 46 payments from 18 companies in 2025. Trend: 2023 $2,758 · 2024 $1,277 · 2025 $1,254
Food & beverage: $1,254
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $174 |
| Boston Scientific Corporation | 2 | $173 |
| Sumitomo Pharma America, Inc. | 5 | $127 |
| Smith+Nephew, Inc. | 4 | $107 |
| Novartis Pharmaceuticals Corporation | 3 | $90 |
| Pacira Pharmaceuticals Incorporated | 2 | $85 |
| Janssen Biotech, Inc. | 3 | $65 |
| Olympus America Inc. | 2 | $62 |
| Antares Pharma, Inc. | 3 | $62 |
| Dendreon Pharmaceuticals LLC | 2 | $51 |
Products named: LUPRON DEPOT, AMS 700, GEMTESA, PLUVICTO, Exparel, STRAVIX PL, XYOSTED, PROVENGE.
Industry payments across IL — which companies pay providers there.
